These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8091236)

  • 1. Obstacles to the accrual of patients to clinical trials in the community setting.
    Winn RJ
    Semin Oncol; 1994 Aug; 21(4 Suppl 7):112-7. PubMed ID: 8091236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical trial accrual among new cancer patients at a community-based cancer center.
    Go RS; Frisby KA; Lee JA; Mathiason MA; Meyer CM; Ostern JL; Walther SM; Schroeder JE; Meyer LA; Umberger KE
    Cancer; 2006 Jan; 106(2):426-33. PubMed ID: 16353206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.
    Sneed RC; May WL; Stencel C
    Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A qualitative assessment of the referral system at district level in Zimbabwe: implications on efficiency and effective delivery of health services.
    Hongoro C; Musonza TG; Macq J; Anozie A
    Cent Afr J Med; 1998 Apr; 44(4):93-7. PubMed ID: 9810401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barriers and facilitators to enrollment in cancer clinical trials: qualitative study of the perspectives of clinical research associates.
    Grunfeld E; Zitzelsberger L; Coristine M; Aspelund F
    Cancer; 2002 Oct; 95(7):1577-83. PubMed ID: 12237928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance in quasi-firms: an example from the Community Clinical Oncology Program.
    Lacey LM; Hynes DM; Kaluzny AD
    J Health Hum Resour Adm; 1992; 14(3):307-26. PubMed ID: 10118501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dental screening and referral of young children by pediatric primary care providers.
    dela Cruz GG; Rozier RG; Slade G
    Pediatrics; 2004 Nov; 114(5):e642-52. PubMed ID: 15520094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of managed care and competition on community-based clinical research.
    Carpenter WR; Weiner BJ; Kaluzny AD; Domino ME; Lee SY
    Med Care; 2006 Jul; 44(7):671-9. PubMed ID: 16799362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgeons: A Future Role in Clinical Trials?
    Rusch VW
    Oncologist; 1997; 2(3):V-VI. PubMed ID: 10388050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overcoming barriers to cancer clinical trial accrual: impact of a mass media campaign.
    Umutyan A; Chiechi C; Beckett LA; Paterniti DA; Turrell C; Gandara DR; Davis SW; Wun T; Chen MS; Lara PN
    Cancer; 2008 Jan; 112(1):212-9. PubMed ID: 18008353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survey of oncologists' perceptions of barriers to accrual of older patients with breast carcinoma to clinical trials.
    Kornblith AB; Kemeny M; Peterson BL; Wheeler J; Crawford J; Bartlett N; Fleming G; Graziano S; Muss H; Cohen HJ;
    Cancer; 2002 Sep; 95(5):989-96. PubMed ID: 12209681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Family pediatrics: report of the Task Force on the Family.
    Schor EL;
    Pediatrics; 2003 Jun; 111(6 Pt 2):1541-71. PubMed ID: 12777595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting the performance of a strategic alliance: an analysis of the Community Clinical Oncology Program.
    Kaluzny AD; Lacey LM; Warnecke R; Hynes DM; Morrissey J; Ford L; Sondik E
    Health Serv Res; 1993 Jun; 28(2):159-82. PubMed ID: 8514498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Community Clinical Oncology Program participation in the Breast Cancer Prevention Trial: factors affecting accrual.
    Klabunde C; Kaluzny A; Ford L
    Cancer Epidemiol Biomarkers Prev; 1995; 4(7):783-9. PubMed ID: 8672997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of factors affecting awareness of and willingness to participate in cancer clinical trials.
    Lara PN; Paterniti DA; Chiechi C; Turrell C; Morain C; Horan N; Montell L; Gonzalez J; Davis S; Umutyan A; Martel CL; Gandara DR; Wun T; Beckett LA; Chen MS
    J Clin Oncol; 2005 Dec; 23(36):9282-9. PubMed ID: 16361626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beware the Medical-Industrial Complex.
    Stevens CW; Glatstein E
    Oncologist; 1996; 1(4):IV-V. PubMed ID: 10388005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organizational barriers to physician participation in cancer clinical trials.
    Somkin CP; Altschuler A; Ackerson L; Geiger AM; Greene SM; Mouchawar J; Holup J; Fehrenbacher L; Nelson A; Glass A; Polikoff J; Tishler S; Schmidt C; Field T; Wagner E
    Am J Manag Care; 2005 Jul; 11(7):413-21. PubMed ID: 16044978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV/AIDS: a minority health issue.
    Cargill VA; Stone VE
    Med Clin North Am; 2005 Jul; 89(4):895-912. PubMed ID: 15925655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.